Valuation: Illumina, Inc.

Capitalization 14.32B 12.43B 11.7B 10.63B 19.67B 1,241B 22.17B 139B 53.04B 568B 53.75B 52.61B 2,089B P/E ratio 2025 *
25.7x
P/E ratio 2026 * 22.3x
Enterprise value 13.94B 12.09B 11.39B 10.35B 19.15B 1,207B 21.57B 135B 51.61B 553B 52.3B 51.19B 2,033B EV / Sales 2025 *
3.29x
EV / Sales 2026 * 3.01x
Free-Float
79.72%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.25%
1 week+4.10%
Current month+10.03%
1 month+7.46%
3 months+6.72%
6 months-33.47%
Current year-32.28%
More quotes
1 week 86.03
Extreme 86.03
91.57
1 month 78.55
Extreme 78.55
91.57
Current year 68.7
Extreme 68.7
153.06
1 year 68.7
Extreme 68.7
156.66
3 years 68.7
Extreme 68.7
248.87
5 years 68.7
Extreme 68.7
555.77
10 years 68.7
Extreme 68.7
555.77
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 24/09/2023
Director of Finance/CFO 49 14/04/2024
Chief Tech/Sci/R&D Officer - 08/08/2023
Director TitleAgeSince
Director/Board Member 70 28/11/2012
Director/Board Member 68 27/01/2016
Director/Board Member 64 27/07/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.25%+4.10%-16.41%-51.68% 14.29B
-0.03%-0.55%+17.76%+165.18% 183B
-0.07%+1.56%+31.56%+181.31% 150B
+1.36%-1.21%-28.59%-20.57% 148B
+1.00%-2.13%-20.99%-17.69% 139B
+0.72%+1.27%-13.17%+4.05% 58.69B
-0.20%-1.76%-16.90%-15.90% 43.4B
+0.58%-4.22%-22.92%-27.47% 38.02B
+1.12%+1.74%+18.95%+28.40% 36.72B
-0.85%-1.34%-10.27% - 32.92B
Average +0.40%-0.32%-6.10%+27.29% 84.4B
Weighted average by Cap. +0.50%-0.51%-1.70%+62.45%
See all sector performances

Financials

2025 *2026 *
Net sales 4.23B 3.67B 3.46B 3.14B 5.81B 367B 6.55B 40.96B 15.67B 168B 15.88B 15.55B 617B 4.39B 3.81B 3.59B 3.26B 6.03B 381B 6.8B 42.51B 16.27B 174B 16.49B 16.14B 641B
Net income 552M 479M 451M 410M 758M 47.81B 854M 5.34B 2.04B 21.9B 2.07B 2.03B 80.5B 628M 545M 513M 466M 862M 54.37B 971M 6.07B 2.32B 24.91B 2.36B 2.31B 91.56B
Net Debt -385M -334M -315M -286M -529M -33.36B -596M -3.73B -1.43B -15.28B -1.45B -1.41B -56.18B -1.11B -963M -907M -824M -1.53B -96.19B -1.72B -10.75B -4.11B -44.06B -4.17B -4.08B -162B
More financial data * Estimated data
Logo Illumina, Inc.
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Employees
9,000
More about the company
Date Price Change Volume
20/06/25 90.49 $ +0.25% 3,182,189
18/06/25 90.26 $ +0.88% 2,028,519
17/06/25 89.47 $ -0.86% 2,387,287
16/06/25 90.25 $ +3.82% 1,790,871
13/06/25 86.93 $ -1.36% 1,612,835

Delayed Quote Nasdaq, June 20, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
90.49USD
Average target price
108.48USD
Spread / Average Target
+19.88%
Consensus

Quarterly revenue - Rate of surprise